Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aspira Women's Health Inc AWHL

Healthcare Biotechnology
Aspira Women's Health Inc. is engaged in the discovery, development, and commercialization of noninvasive, artificial intelligence (AI)-powered tests to aid in the diagnosis of gynecologic diseases. The Company's portfolio includes OvaWatch and the Ova1Plus workflow, offered to clinicians as OvaSuite. OvaWatch is used to assess ovarian cancer risk for women with an adnexal mass where their... see more

Recent & Breaking News (OTCQB:AWHL)

Aspira Women's Health Provides Update on ARPA-H Sprint Program Partnership to Advance Women's Health

ACCESS Newswire 3 days ago

Aspira Announces First Quarter 2025 Financial Results and Provides Business Update

ACCESS Newswire May 19, 2025

Aspira Successfully Completes Application to the OTCQB

ACCESS Newswire May 7, 2025

Aspira Reaches Another ARPA-H Milestone, Eligible to Receive Additional $1.5 Million in Second Quarter

ACCESS Newswire May 1, 2025

Aspira Women's Health Inc. to Begin Trading April 17th On OTC Under the Symbol "AWHL"

ACCESS Newswire April 17, 2025

Aspira Women's Health Inc. Announces Receipt of Delisting Notification from Nasdaq

ACCESS Newswire April 16, 2025

Aspira Appoints Three New Directors, Executes $2.0 Million Equity Purchase Agreement

ACCESS Newswire April 8, 2025

Aspira Receives $1.5 million Milestone Payment from the ARPA-H Sprint for Women's Health Award

ACCESS Newswire March 31, 2025

Aspira Women's Health Reports Fourth Quarter and Full Year 2024 Financial Results

ACCESS Newswire March 27, 2025

Aspira Women's Health Announces Closing of $1.37 Million Private Placement of Convertible Notes

ACCESS Newswire March 11, 2025

Aspira Women's Health Submits Request for Withdrawal of Form S-1 Registration Statement

ACCESS Newswire February 13, 2025

Aspira Women's Health Announces Appointment of Ellen Beausang to the Board of Directors

ACCESS Newswire February 11, 2025

Aspira Women's Health Announces the Appointment of Mike Buhle as SVP of Commercial Operations

ACCESS Newswire January 10, 2025

Aspira Women's Health Announces Appointment of Dr. Sandra Milligan as Interim CEO

GlobeNewswire December 16, 2024

Aspira Women's Health Successfully Reaches the First Milestone of the ARPA-H $10 Million Award

GlobeNewswire December 3, 2024

Aspira Women's Health Reports Selected Third Quarter 2024 Financial Results

GlobeNewswire November 14, 2024

Aspira Women's Health Expands Co-Marketing and Distribution Collaboration with BioReference® to Include OvaWatch®

GlobeNewswire November 7, 2024

Aspira Women's Health to Announce Third Quarter Earnings Results and Host a Conference Call on Thursday, November 14, 2024

GlobeNewswire November 4, 2024

Aspira Women's Health Issues Letter to Shareholders and Announces Virtual Research & Development Day on October 29, 2024

GlobeNewswire October 25, 2024

Aspira Women's Health Selected to Receive $10 Million Award from ARPA-H's Sprint for Women's Health

GlobeNewswire October 23, 2024